Commercial, Solar, Sourcing Renewables  -  January 17, 2024

AstraZeneca, Lonza, Novartis, Novo Nordisk, Roche Sign RE Agreement

AstraZeneca, Lonza, Novartis, Novo Nordisk and Roche signed a three-year renewable energy supply agreement for 200 gigawatt-hours (GWh) of green power annually, starting in 2024.

The agreement between the five pharmaceutical companies and Envision Energy, a green technology company, will result in annual carbon dioxide equivalent savings of approximately 120,000 tons, according to a statement. 

The three-year renewable energy supply agreement was announced during the World Economic Forum Annual Meeting in Davos, Switzerland. 

Four of the companies - AstraZeneca, Novartis, Novo Nordisk, and Roche - are members of the Sustainable Markets Initiative Health Systems Task Force, which was launched by His Majesty King Charles III.

Share this valuable information with your colleagues using the buttons below: